Precision Medicine in Interventional Cardiology

Precision medicine has recently become widely advocated. It revolves around the individual patient, taking into account genetic, biomarker, phenotypic or psychosocial characteristics and uses biological, mechanical and/or personal variables to optimise individual therapy. In silico testing, such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hokken, Thijmen W, Ribeiro, Joana M, De Jaegere, Peter P, Van Mieghem, Nicolas M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203877/
https://www.ncbi.nlm.nih.gov/pubmed/32382319
http://dx.doi.org/10.15420/icr.2019.23
_version_ 1783529953866809344
author Hokken, Thijmen W
Ribeiro, Joana M
De Jaegere, Peter P
Van Mieghem, Nicolas M
author_facet Hokken, Thijmen W
Ribeiro, Joana M
De Jaegere, Peter P
Van Mieghem, Nicolas M
author_sort Hokken, Thijmen W
collection PubMed
description Precision medicine has recently become widely advocated. It revolves around the individual patient, taking into account genetic, biomarker, phenotypic or psychosocial characteristics and uses biological, mechanical and/or personal variables to optimise individual therapy. In silico testing, such as the Virtual Physiological Human project, is being promoted to predict risk and to test treatments and medical devices. It combines artificial intelligence and computational modelling to select the best therapeutic option for the individual patient.
format Online
Article
Text
id pubmed-7203877
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-72038772020-05-07 Precision Medicine in Interventional Cardiology Hokken, Thijmen W Ribeiro, Joana M De Jaegere, Peter P Van Mieghem, Nicolas M Interv Cardiol Expert Opinion Precision medicine has recently become widely advocated. It revolves around the individual patient, taking into account genetic, biomarker, phenotypic or psychosocial characteristics and uses biological, mechanical and/or personal variables to optimise individual therapy. In silico testing, such as the Virtual Physiological Human project, is being promoted to predict risk and to test treatments and medical devices. It combines artificial intelligence and computational modelling to select the best therapeutic option for the individual patient. Radcliffe Cardiology 2020-04-23 /pmc/articles/PMC7203877/ /pubmed/32382319 http://dx.doi.org/10.15420/icr.2019.23 Text en Copyright © 2020, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Expert Opinion
Hokken, Thijmen W
Ribeiro, Joana M
De Jaegere, Peter P
Van Mieghem, Nicolas M
Precision Medicine in Interventional Cardiology
title Precision Medicine in Interventional Cardiology
title_full Precision Medicine in Interventional Cardiology
title_fullStr Precision Medicine in Interventional Cardiology
title_full_unstemmed Precision Medicine in Interventional Cardiology
title_short Precision Medicine in Interventional Cardiology
title_sort precision medicine in interventional cardiology
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203877/
https://www.ncbi.nlm.nih.gov/pubmed/32382319
http://dx.doi.org/10.15420/icr.2019.23
work_keys_str_mv AT hokkenthijmenw precisionmedicineininterventionalcardiology
AT ribeirojoanam precisionmedicineininterventionalcardiology
AT dejaegerepeterp precisionmedicineininterventionalcardiology
AT vanmieghemnicolasm precisionmedicineininterventionalcardiology

Ejemplares similares